Viral Inactivation Market

Viral Inactivation Market (Method – Chemical and Radiation; Application – Blood and Blood Products, Vaccines, and Cell and Tissue Culture; End-user - Pharmaceutical and Biotechnology Companies, Blood Banks and Hospitals, and Contract Research Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL21497
  • Published On : Sep 2017
  • No. of Pages : 227
  • Category : Healthcare

Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2. Assumptions and Research Methodology

Chapter 3. Executive Summary: Global Viral Inactivation market               

Chapter 4. Market Overview
4.1. Introduction
       4.1.1. Viral Inactivation Method Introduction
       4.1.2. Industry Evolution / Developments

Chapter 5. Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Opportunities
5.4. Trends
5.5. Viral Inactivation market  Analysis and Forecast, 2017 – 2025
       5.5.1. Market Revenue Projections (US$ Mn), 2017-2025
5.6. Porter’s five forces analysis
5.7. Market Outlook

Chapter 6. Global Viral Inactivation market  Analysis and Forecasts, by Method
6.1. Key Findings 
6.2. Introduction 
6.3. Market size (US$ Mn) Forecast, by Method, 2017-2025
       6.3.1. Chemical method
                6.3.1.1. Solvent & Detergents
                6.3.1.2. Alkylating Agents
                6.3.1.3. pH Concentration
       6.3.2. Radiation Method
       6.3.3. Other Methods
6.4. Market Attractiveness Analysis, by Method
6.5. Key Trends

Chapter 7. Global Viral Inactivation market  Analysis and Forecasts, by Application
7.1. Key Findings
7.2. Introduction
7.3. Market size (US$ Mn) Forecast, by Application, 2017-2025
       7.3.1. Blood and Blood Products
       7.3.2. Vaccines
       7.3.3. Cell and Tissue Culture 
7.4. Market Attractiveness, by Application

Chapter 8. Global Viral Inactivation market  Analysis and Forecasts, by End-user
8.1. Key Findings
8.2. Introduction
8.3. Market size (US$ Mn) Forecast by End-user, 2017-2025
       8.3.1. Pharmaceutical and Biotechnology Companies
       8.3.2. Blood banks and Hospitals
       8.3.3. Contract Research Organizations
       8.3.4. Others 
8.4. Market Attractiveness by End-user

Chapter 9. Global Viral Inactivation market  Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Global Market Scenario
9.3. Market Value (US$ Mn) Forecast, by Region, 2017-2025
       9.3.1. North America
       9.3.2. Europe
       9.3.3. Asia Pacific 
       9.3.4. Latin America
       9.3.5. Middle East & Africa
9.4. Market Attractiveness, by Region

Chapter 10. North America Viral Inactivation market  Analysis and Forecast
10.1. Key Findings 
10.2. Market Overview
10.3. Market Value (US$ Mn) Forecast, by Country, 2017-2025
       10.3.1. U.S.
       10.3.2. Canada
10.4. Market size (US$ Mn) Forecast, by Method, 2017-2025
       10.4.1. Chemical method
10.4.1.1. Solvent & Detergents
10.4.1.2. Alkylating Agents
10.4.1.3. pH Concentration
       10.4.2. Radiation Method
       10.4.3. Other Methods
10.5. Market size (US$ Mn) Forecast, by Application, 2017-2025
       10.5.1. Blood and Blood Products
       10.5.2. Vaccines
       10.5.3. Cell and Tissue Culture 
10.6. Market size (US$ Mn) Forecast by End-user, 2017-2025
       10.6.1. Pharmaceutical and Biotechnology Companies
       10.6.2. Blood banks and Hospitals
       10.6.3. Contract Research Organizations
       10.6.4. Others 
10.7. Market Attractiveness Analysis 
       10.7.1. By Country
       10.7.2. By Method
       10.7.3. By Application
       10.7.4. By End-user
10.8. Key Trends

Chapter 11. Europe Viral Inactivation market  Analysis and Forecast
11.1. Key Findings 
11.2. Market Overview
11.3. Market size (US$ Mn) Forecast By Country, 2017-2025
       11.3.1. Germany
       11.3.2. U.K.
       11.3.3. France
       11.3.4. Spain
       11.3.5. Italy
       11.3.6. Rest of Europe
11.4. Market size (US$ Mn) Forecast, by Method, 2017-2025
       11.4.1. Chemical method
                11.4.1.1. Solvent & Detergents
                11.4.1.2. Alkylating Agents
                11.4.1.3. pH Concentration
       11.4.2. Radiation Method
       11.4.3. Other Methods
11.5. Market size (US$ Mn) Forecast, by Application, 2017-2025
       11.5.1. Blood and Blood Products
       11.5.2. Vaccines
       11.5.3. Cell and Tissue Culture 
11.6. Market size (US$ Mn) Forecast by End-user, 2017-2025
       11.6.1. Pharmaceutical and Biotechnology Companies
       11.6.2. Blood banks and Hospitals
       11.6.3. Contract Research Organizations
       11.6.4. Others 
11.7. Market Attractiveness Analysis 
       11.7.1. By Country
       11.7.2. By Method
       11.7.3. By Application
       11.7.4. By End-user
11.8. Key Trends

Chapter 12. Asia Pacific Viral Inactivation market Analysis and Forecast
12.1. Key Findings / Developments
12.2. Market Overview
12.3. Market size (US$ Mn) Forecast, by Country, 2017-2025
       12.3.1. China
       12.3.2. India
       12.3.3. Japan
       12.3.4. Australia & New Zealand
       12.3.5. Rest of Asia Pacific
12.4. Market size (US$ Mn) Forecast, by Method, 2017-2025
       12.4.1. Chemical method
                12.4.1.1. Solvent & Detergents
                12.4.1.2. Alkylating Agents
                12.4.1.3. pH Concentration
       12.4.2. Radiation Method
       12.4.3. Other Methods
12.5. Market size (US$ Mn) Forecast, by Application, 2017-2025
       12.5.1. Blood and Blood Products
       12.5.2. Vaccines
       12.5.3. Cell and Tissue Culture 
12.6. Market size (US$ Mn) Forecast by End-user, 2017-2025
       12.6.1. Pharmaceutical and Biotechnology Companies
       12.6.2. Blood banks and Hospitals
       12.6.3. Contract Research Organizations
       12.6.4. Others 
12.7. Market Attractiveness Analysis 
       12.7.1. By Country
       12.7.2. By Method
       12.7.3. By Application
       12.7.4. By End-user
12.8. Key Trends

Chapter 13. Latin America Viral Inactivation market Analysis and Forecast
13.1. Key Findings / Developments
13.2. Market Overview
13.3. Market Size (US$ Mn) Forecast, by Country, 2017-2025
       13.3.1. Brazil
       13.3.2. Mexico
       13.3.3. Rest of Latin America
13.4. Market size (US$ Mn) Forecast, by Method, 2017-2025
       13.4.1. Chemical method
                13.4.1.1. Solvent & Detergents
                13.4.1.2. Alkylating Agents
                13.4.1.3. pH Concentration
       13.4.2. Radiation Method
       13.4.3. Other Methods
13.5. Market size (US$ Mn) Forecast, by Application, 2017-2025
       13.5.1. Blood and Blood Products
       13.5.2. Vaccines
       13.5.3. Cell and Tissue Culture 
13.6. Market size (US$ Mn) Forecast by End-user, 2017-2025
       13.6.1. Pharmaceutical and Biotechnology Companies
       13.6.2. Blood banks and Hospitals
       13.6.3. Contract Research Organizations
       13.6.4. Others 
13.7. Market Attractiveness Analysis 
       13.7.1. By Country
       13.7.2. By Method
       13.7.3. By Application
       13.7.4. By End-user
13.8. Key Trends

Chapter 14. Middle East and Africa Viral Inactivation market Analysis and Forecast
14.1. Key Findings / Developments
14.2. Market Overview
14.3. Market size (US$ Mn) Forecast, by Country, 2017-2025
       14.3.1. GCC Countries
       14.3.2. South Africa
       14.3.3. Rest of Middle East and Africa
14.4. Market size (US$ Mn) Forecast, by Method, 2017-2025
       14.4.1. Chemical method
                14.4.1.1. Solvent & Detergents
                14.4.1.2. Alkylating Agents
                14.4.1.3. pH Concentration
       14.4.2. Radiation Method
       14.4.3. Other Methods
14.5. Market size (US$ Mn) Forecast, by Application, 2017-2025
       14.5.1. Blood and Blood Products
       14.5.2. Vaccines
       14.5.3. Cell and Tissue Culture 
14.6. Market size (US$ Mn) Forecast by End-user, 2017-2025
       14.6.1. Pharmaceutical and Biotechnology Companies
       14.6.2. Blood banks and Hospitals
       14.6.3. Contract Research Organizations
       14.6.4. Others 
14.7. Market Attractiveness Analysis 
       14.7.1. By Country
       14.7.2. By Method
       14.7.3. By Application
       14.7.4. By End-user
14.8. Key Trends

Chapter 15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
       15.2.1. Parker Hannifin Corporation
                15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                15.2.1.2. Product Portfolio
                15.2.1.3. SWOT Analysis
                15.2.1.4. Strategic Overview
       15.2.2. Merck & Co., Inc.  
                15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                15.2.2.2. Product Portfolio
                15.2.2.3. SWOT Analysis
                15.2.2.4. Strategic Overview
       15.2.3. Shandong Weigao Group Medical Polymer Company Limited
                15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                15.2.3.2. Product Portfolio
                15.2.3.3. SWOT Analysis
                15.2.3.4. Financial Overview
                15.2.3.5. Strategic Overview
       15.2.4. Sartorius AG
                15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                15.2.4.2. Product Portfolio
                15.2.4.3. SWOT Analysis
                15.2.4.4. Financial Overview
                15.2.4.5. Strategic Overview
       15.2.5. Cerus Corporation
                15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                15.2.5.2. Product Portfolio
                15.2.5.3. SWOT Analysis
                15.2.5.4. Financial Overview
                15.2.5.5. Strategic Overview
       15.2.6. Macopharma SA 
                15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                15.2.6.2. Product Portfolio
                15.2.6.3. SWOT Analysis
                15.2.6.4. Financial Overview
                15.2.6.5. Strategic Overview
       15.2.7. Terumo BCT, Inc. 
                15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                15.2.7.2. Product Portfolio
                15.2.7.3. SWOT Analysis
                15.2.7.4. Financial Overview
                15.2.7.5. Strategic Overview
       15.2.8. Thermo Fisher Scientific Inc.
                15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                15.2.8.2. Product Portfolio
                15.2.8.3. SWOT Analysis
                15.2.8.4. Financial Overview
                15.2.8.5. Strategic Overview
       15.2.9. V.I.P.S. SA
                15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                15.2.9.2. Product Portfolio
                15.2.9.3. SWOT Analysis
                15.2.9.4. Financial Overview
                15.2.9.5. Strategic Overview

List of Tables

Table 01: Global Viral Inactivation Market Size (US$ Mn) Forecast, by Method, 2015–2025
Table 02: Global Market Size (US$ Mn) Forecast, Chemical Method, 2015–2025
Table 03: Global Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 04: Global Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 05: Global Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 06: North America Viral Inactivation Market Size (US$ Mn) Forecast, by Country/ Sub-region, 2015–2025
Table 07: North America Market Size (US$ Mn) Forecast, by Method, 2015–2025
Table 08: North America Market Size (US$ Mn) Forecast, by Chemical method, 2015–2025
Table 09: North America Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 10: North America Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 11: Europe Viral Inactivation Market Value (US$ Mn) Forecast, by Country / Sub-region, 2015–2025
Table 12: Europe Market Value (US$ Mn) Forecast, by Method, 2015–2025
Table 13: Europe Market Size (US$ Mn) Forecast, by Chemical Method, 2015–2025
Table 14: Europe Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 15: Europe Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 16: Asia Pacific Viral Inactivation Market Value (US$ Mn) Forecast, by Country/ Sub-region, 2015–2025
Table 17: Asia Pacific Market Value (US$ Mn) Forecast, by Method, 2015–2025
Table 18: Asia Pacific Market Size (US$ Mn) Forecast, by Chemical Method, 2015–2025
Table 19: Asia Pacific Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 20: Asia Pacific Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 21: Latin America Viral Inactivation Market Size (US$ Mn) Forecast, by Country/ Sub-region, 2015–2025
Table 22: Latin America Market Size (US$ Mn) Forecast, by Method, 2015–2025
Table 23: Latin America Market Size (US$ Mn) Forecast, by Chemical Method, 2015–2025
Table 24: Latin America Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 25: Latin America Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 26: Middle East & Africa Viral Inactivation Market Size (US$ Mn) Forecast, by Country/ Sub-region, 2015–2025
Table 27: Middle East & Africa Market Size (US$ Mn) Forecast, by Method, 2015–2025
Table 28: Middle East & Africa Market Size (US$ Mn) Forecast, by Chemical Method, 2015–2025
Table 29: Middle East & Africa Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 30: Middle East & Africa Market Size (US$ Mn) Forecast, by End-user, 2015–2025

List of Figures

Figure 01: Global Viral Inactivation Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 02: Global Market Value Share, by Method (2016)
Figure 03: Global Market Value Share, by Application (2016)
Figure 04: Global Market Value Share, by End-user (2016)
Figure 05: Global Market Value Share, by Region (2016)
Figure 06: Global Market Value Share Analysis, by Method, 2016 and 2025
Figure 07: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical Method, 2016–2025
Figure 08: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Radiation Method, 2016–2025
Figure 09: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Methods, 2016–2025
Figure 10: Global Market Attractiveness Analysis, by Method, 2017–2025
Figure 11: Global Market Value Share Analysis, by Application, 2016 and 2025
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood and Blood Products, 2017–2025
Figure 13: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2017–2025
Figure 14: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cell & Tissue Culture, 2017–2025
Figure 15: Global Market Attractiveness Analysis, by Application, 2017–2025
Figure 16: Global Market Value Share Analysis, by End-user, 2016 and 2025
Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pharmaceutical and Biotechnology companies, 2016–2025
Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Banks and Hospitals, 2016–2025
Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2016–2025
Figure 20: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2025
Figure 21: Global Market Attractiveness
Figure 22: Global Market Value Share Analysis, by Region, 2016 and 2025
Figure 23: Global Market Attractiveness Analysis, by Region, 2017–2025
Figure 24: North America Viral Inactivation Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2025
Figure 25: North America Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 26: North America Market Value Share Analysis, by Country/ Sub-region, 2016 and 2025
Figure 27: North America Market Value Share Analysis, by Method, 2016 and 2025
Figure 28: North America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical method, 2016–2025
Figure 29: North America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Radiation method,     2016–2025
Figure 30: North America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Methods, 2016–2025
Figure 31: North America Market Value Share Analysis, by Application, 2016 and 2025
Figure 32: North America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood and Blood Products, 2016–2025
Figure 33: North America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2016–2025
Figure 34: North America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cell & Tissue Culture, 2016–2025
Figure 35: North America Market Value Share Analysis, by End-user, 2016 and 2025
Figure 36: North America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pharmaceutical and Biotechnology Companies, 2016–2025
Figure 37: North America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Banks and Hospitals, 2016–2025
Figure 38: North America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2016–2025
Figure 39: North America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2025
Figure 40: North America Market Attractiveness Analysis, by Method, 2017–2025
Figure 41: North America Market Attractiveness Analysis, by Application, 2017–2025
Figure 42: North America Market Attractiveness Analysis, by End-user, 2017-2025
Figure 43: Europe Viral Inactivation Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2025
Figure 44: Europe Market Attractiveness Analysis, by Country / Sub-region, 2017–2025
Figure 45: Europe Market Value Share Analysis, by Country / Sub-region, 2016 and 2025
Figure 46: Europe Market Value Share Analysis, by Method, 2016 and 2025
Figure 47: Europe Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical, 2016–2025
Figure 48: Europe Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Radiation Method, 2016–2025
Figure 49: Europe Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Methods, 2016–2025
Figure 50: Europe Market Value Share Analysis (US$ Mn), by Application, 2016 and 2025
Figure 51: Europe Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood & Blood Products, 2016–2025
Figure 52: Europe Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2016–2025
Figure 53: Europe Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cell & Tissue Culture, 2016–2025
Figure 54: Europe Market Value share Analysis, by End-user, 2016 and 2025
Figure 55: Europe Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pharmaceutical & Biotechnology Companies, 2016–2025
Figure 56: Europe Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Banks & Hospitals, 2016–2025
Figure 57: Europe Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organization, 2016–2025
Figure 58: Europe Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2025
Figure 59: Europe Market Attractiveness Analysis, by Method, 2017–2025
Figure 60: Europe Market Attractiveness Analysis, by Application, 2017–2025
Figure 61: Europe Market Attractiveness Analysis, by End-user, 2017–2025
Figure 62: Asia Pacific Viral Inactivation Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2025
Figure 63: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 64: Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 65: Asia Pacific Market Value Share Analysis, by Method, 2016 and 2025
Figure 66: Asia Pacific Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical Method, 2016–2025
Figure 67: Asia Pacific Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Radiation Method, 2016–2025
Figure 68: Asia Pacific Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Methods, 2016–2025
Figure 69: Asia Pacific Market Value Share Analysis, by Application, 2016 and 2025
Figure 70: Asia Pacific Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood & Blood Products, 2016–2025
Figure 71: Asia Pacific Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2016–2025
Figure 72: Asia Pacific Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cell & Tissue Culture, 2016–2025
Figure 73: Asia Pacific Market Value share Analysis, by End-user, 2016 and 2025
Figure 74: Asia Pacific Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pharmaceutical & Biotechnology Companies, 2016–2025
Figure 75: Asia Pacific Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Banks & Hospitals, 2016–2025
Figure 76: Asia Pacific Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2016–2025
Figure 77: Asia Pacific Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2025
Figure 78: Asia PacificMarket Attractiveness Analysis, by Method, 2017–2025
Figure 79: Asia Pacific Market Attractiveness Analysis, by Application, 2017–2025
Figure 80: Asia Pacific Market Attractiveness Analysis, by End-user, 2017–2025
Figure 81: Latin America Viral Inactivation Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2025
Figure 82: Latin America Market Attractiveness Analysis, by Country/Sub-region, 2017-2025
Figure 83: Latin America Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 84: Latin America Market Value Share Analysis, by Method, 2016 and 2025
Figure 85: Latin America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical Method, 2016–2025
Figure 86: Latin America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Radiation method, 2016–2025
Figure 87: Latin America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by other methods 2016–2025
Figure 88: Latin America Market Value Share Analysis, by Application, 2016 and 2025
Figure 89: Latin America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood and Blood Products 2016–2025
Figure 90: Latin America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2016–2025
Figure 91: Latin America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cell and Tissue Culture, 2016–2025
Figure 92: Latin America Market Value Share Analysis, by End-user, 2016 and 2025
Figure 93: Latin America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pharmaceutical and Biotechnology companies, 2016–2025
Figure 94: Latin America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Banks and Hospitals, 2016–2025
Figure 95: Latin America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations 2016–2025
Figure 96: Latin America Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2025
Figure 97: Latin America Market Attractiveness Analysis, by Method, 2017–2025
Figure 98: Latin America arket Attractiveness Analysis, by Application, 2017–2025
Figure 99: Latin America Market Attractiveness Analysis, by End-user, 2017-2025
Figure 100: Middle East & Africa Viral Inactivation Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2025
Figure 101: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2017-2025
Figure 102: Middle East & Africa Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 103: Middle East & Africa Market Value Share Analysis, by Method, 2016 and 2025
Figure 104: Middle East & Africa Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical Method, 2016–2025
Figure 105: Middle East & Africa Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Radiation method, 2016–2025
Figure 106: Middle East & Africa Market Revenue (US$ Mn) and Y-o-Y Growth (%), by other methods, 2016–2025
Figure 107: Middle East & Africa Market Value Share Analysis, by Application, 2016 and 2025
Figure 108: Middle East & Africa Blood and Blood Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2025
Figure 109: Middle East & Africa Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2025
Figure 110: Middle East & Africa Cell Culture Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2025
Figure 111: Middle East & Africa Market Value Share Analysis, by End-user, 2016 and 2025
Figure 112: Middle East & Africa Pharmaceutical and Biotechnology companies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2025
Figure 113: Middle East & Africa Blood Banks and Hospitals Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2025
Figure 114: Middle East & Africa Contract Research Organizations Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2025
Figure 115: Middle East & Africa Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2025
Figure 116: Middle East & Africa Market Attractiveness Analysis, by Method, 2017–2025
Figure 117: Middle East & Africa Market Attractiveness Analysis, by Application, 2017–2025
Figure 118: Middle East & Africa Market Attractiveness Analysis, by End-user, 2017–2025